IonQ Executive Chair Sells $59.8M in Shares Through Planned Transaction

IonQ Executive Chair Peter Chapman reported significant insider transactions on June 20, 2025, executed through a pre-planned Rule 10b5-1 trading plan established on March 14, 2025.

Rhea-AI Filing Summary

IonQ Executive Chair Peter Chapman reported significant insider transactions on June 20, 2025, executed through a pre-planned Rule 10b5-1 trading plan established on March 14, 2025.

Key transaction details:

• Exercised 1,497,311 employee stock options at $0.1334 per share
• Subsequently sold the same number of shares at a weighted average price of $39.931 (range: $39.50-$41.40)
• Post-transaction holdings: 390,329 shares held directly and 107,661 remaining stock options

The transactions were executed under a Rule 10b5-1 plan, which provides a safe harbor from insider trading allegations by establishing predetermined trading parameters. Chapman's remaining stock options are fully vested and exercisable, with an expiration date of May 16, 2029.

Positive

• None.

Negative

• Executive Chair Peter Chapman sold 1,497,311 shares worth approximately $59.8M (at avg price $39.93) through a planned 10b5-1 transaction, reducing his direct holdings by 79% from 1,887,640 to 390,329 shares

Insider Trade Summary

Exercise and Sale: 1,497,311 shares ($59.58M approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Chapman Peter Hume

Role Executive Chair

Sold 1,497,311 shs ($59.79M)

Approx. gross sale proceeds $59.79M

Approx. exercise cost $210K

Approx. pre-tax spread $59.58M

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy)	1,497,311	$0.1334	$200K
Exercise	Common Stock	1,497,311	$0.1334	$200K
Sale	Common Stock	1,497,311	$39.931	$59.79M

Holdings After Transaction: Employee Stock Option (right to buy) — 107,661 contracts (Direct); Common Stock — 390,329 shares (Direct)

Footnotes (3)

1. F1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $41.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. All of the shares subject to this option are fully vested and exercisable as of the date hereof.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IONQ shares did Peter Chapman sell on June 20, 2025?

Peter Chapman sold 1,497,311 shares of IONQ common stock on June 20, 2025 at a weighted average price of $39.931 per share.

What is Peter Chapman's role at IONQ?

Peter Chapman serves as both Director and Executive Chair of IonQ, Inc., as disclosed in the Form 4 filing.

Was IONQ insider Peter Chapman's stock sale planned?

Yes, the transactions were executed pursuant to a Rule 10b5-1 trading plan that Chapman adopted on March 14, 2025, indicating this was a pre-planned sale rather than spontaneous trading.

What was the price range of IONQ shares sold by Chapman?

The shares were sold in multiple transactions at prices ranging from $39.50 to $41.40 per share, with a weighted average price of $39.931.

How many IONQ shares does Peter Chapman still own after the June 20, 2025 transactions?

After the transactions, Chapman directly owns 390,329 shares of common stock and 107,661 employee stock options exercisable at $0.14 per share that expire on May 16, 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/20/2025 - 09:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chapman Peter Hume

(Last) (First) (Middle)

C/O IONQ, INC.

4505 CAMPUS DRIVE

(Street)

COLLEGE PARK MD 20740

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IonQ, Inc. [ IONQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chair

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/20/2025		M(1)		1,497,311	A	$0.1334	1,887,640	D
Common Stock	06/20/2025		S(1)		1,497,311	D	$39.931(2)	390,329	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$0.14	06/20/2025		M(1)			1,497,311	(3)	05/16/2029	Common Stock	8,096,905	$0.1334	107,661	D

Explanation of Responses:

1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $41.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. All of the shares subject to this option are fully vested and exercisable as of the date hereof.

	/s/ Kevin Caimi, Attorney-in-Fact	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.